Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care (Q45050933)
Jump to navigation
Jump to search
scientific article published in October 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care |
scientific article published in October 2004 |
Statements
1 reference
Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care (English)
1 reference
Henry A Nasrallah
1 reference
John W Newcomer
1 reference
1 October 2004
1 reference
1 reference
Identifiers
1 reference